Health Statistics : Lupus

  • March 2011
  • -
  • Datamonitor

In 2010, Datamonitor estimates that there were about 404,300 prevalent cases of systemic lupus erythematosus (SLE) in the seven major industries, with approximately 80-90% of these cases in women between 45 and 64 years of age. The number of prevalent cases is expected to increase to approximately 420,000 cases by 2020.Gain insight to sector opportunity, including a robust 10-year prevalence projection of prevalent systemic lupus erythematosus cases.Understand the key epidemiologic risk factors associated with systemic lupus erythematosus.Between 2010 and 2020, Datamonitor expects to see an overall increase in the number of prevalent cases of systemic lupus erythematosus in the US, France, Spain, and the UK. The largest increase is expected in the US. This is due to the fact that the population in women aged 45-64 is increasing in these countries.A decrease in prevalent cases of systemic lupus erythematosus is expected in Japan, Germany, and Italy. The largest decrease is expected in Japan. This is due to the fact that the population in women aged 45-64 is decreasing in these countries, along with the population on the whole.Women aged between 45 and 64 are expected to constitute approximately 80-90% of cases of systemic lupus erythematosus.What are the most robust sources for systemic lupus erythematosus prevalence?How will the patient population change of the next decade in the US, Japan, and the five major EU industry s (France, Germany, Italy, Spain, and the UK)?How do changes in population structure and risk factors affect the trend in prevalent systemic lupus erythematosus cases?

Table Of Contents

Summary
Risk factors
Epidemiologic projection
OVERVIEW
Catalyst
Summary
DISEASE DEFINITION AND DIAGNOSIS CRITERIA
Diagnosis criteria
MANIFESTATION OF DISEASE
Arthritis
Cutaneous symptoms
Lupus nephritis
Central nervous system
Vasculitis
GLOBAL VARIATION AND HISTORICAL TRENDS
Morbidity and mortality
Incidence
Prevalence
RISK FACTORS
Race and ethnicity
Gender
Age
Genetics
Environment
CO-MORBIDITIES
Cardiovascular diseases
Bacterial infections
EPIDEMIOLOGIC FORECASTING
Sources of epidemiologic data
Description of methods
US
Japan
France
Germany
Italy
Spain
UK
EPIDEMIOLOGIC RESULTS
Current prevalent cases and future trends
Annual growth rate of disease population
DISCUSSION
Strengths and limitations of Datamonitor’s epidemiologic projections
BIBLIOGRAPHY
Journal papers
Websites
Datamonitor reports
APPENDIX
Module methodology

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Parkinson's Disease - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Parkinson's Disease - Global Drug Forecast and Market Analysis to 2022

  • $ 9 995
  • Industry report
  • March 2014
  • by Global Data

PharmaPoint: Parkinson's Disease - Global Drug Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, ...

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

  • $ 9 995
  • Industry report
  • April 2014
  • by Global Data

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most ...

Analytical Tool - Hematological Cancers

Analytical Tool - Hematological Cancers

  • $ 8 925
  • Industry report
  • March 2014
  • by Bioseeker

"Analytical Tool - Hematological Cancers" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers. It is ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.